99mTc-fanolesomab Palatin Technologies
Related Experiment Video
Updated: Aug 30, 2026
13:45
Hybrid µCT-FMT imaging and image analysis
Published on: June 4, 2015
Charito Love1, Christopher J Palestro
1Long Island Jewish Medical Center, Division of Nuclear Medicine, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.
Idrugs : the Investigational Drugs Journal
|November 6, 2003
Abstract:
99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)